- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03178513
Post-Acute Physician Home Visit Program
Post-Acute Physician Home Visits: A Randomized Controlled Trial
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Stati Uniti, 02130
- Brigham and Women's Faulkner Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Resides within either a 5-mile or 20-minute driving radius of Brigham and Women's Hospital (BWH) or Brigham and Women's Faulkner Hospital (BWFH) emergency room
- Has capacity to consent to study
- >=18 years old
Exclusion Criteria:
- Undomiciled
- In police custody
- Domestic violence screen positive
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Home visit
A participant in this arm will receive a home visit after discharge from the hospital.
|
The visit will be entirely patient tailored, last approximately one hour, and at a minimum will entail:
|
Nessun intervento: Usual Care
A participant in this arm will not receive a home visit after discharge from the hospital.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
New or worsening symptoms
Lasso di tempo: 30 days after discharge from hospital
|
"Since you got home from the hospital, have you had any symptoms at all?" If no, stop. If yes, continue. "I'm going to read off a list of symptoms, and I want you to tell me if that symptom is new or has gotten worse since you left the hospital. Please don't include symptoms that have stayed the same since you were in the hospital." For each affirmative, double check if the symptom is new or has gotten worse since getting out of the hospital. Only if new or worse, mark yes. |
30 days after discharge from hospital
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Misura di transizione assistenziale a 3 elementi, punteggio
Lasso di tempo: 30 giorni dopo la dimissione
|
30 giorni dopo la dimissione
|
|
Total cost, 30-days post discharge
Lasso di tempo: Day of discharge to 30 days later
|
Day of discharge to 30 days later
|
|
Total reimbursement, 30-days post discharge
Lasso di tempo: Day of discharge to 30 days later
|
Day of discharge to 30 days later
|
|
Primary care provider follow-up within 14 days, y/n
Lasso di tempo: Day of discharge to 14 days later
|
Day of discharge to 14 days later
|
|
Ability to carry out the discharge plan, score
Lasso di tempo: 30 days after discharge
|
I would like to ask you about some more problems that you might have faced after you left the hospital one month ago.
I will read some statements and ask if you agree or disagree.
|
30 days after discharge
|
Change in medication list due to home visit, y/n
Lasso di tempo: Day of home visit
|
Physician-initiated medication change during home visit
|
Day of home visit
|
Receipt of prescribed medicines following discharge, y/n
Lasso di tempo: 30 days after discharge
|
Pharmacy confirmation
|
30 days after discharge
|
Unplanned 30-day readmission(s) after index hospitalization, y/n
Lasso di tempo: 30 days after discharge
|
30 days after discharge
|
|
Unplanned 30-day readmission(s) after index hospitalization, #
Lasso di tempo: 30 days after discharge
|
30 days after discharge
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Global satisfaction with care, score
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Days at home since discharge, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All-cause 30-day readmission(s) after index hospitalization, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All-cause 30-day readmission(s) after index hospitalization, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) observation stay(s) after index hospitalization, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) observation stay(s) after index hospitalization, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) visit(s) after index hospitalization, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Emergency Department (ED) visit(s) after index hospitalization, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Imaging, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Imaging, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Lab orders, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Lab orders, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Physician visits, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Physician visits, #
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Home health utilization, days
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Home health utilization, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
All cause 30-day mortality, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Unplanned 30-day mortality, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Change in medication list due to error at discharge, y/n
Lasso di tempo: Visit date
|
Exploratory
|
Visit date
|
Pneumococcal vaccination if appropriate, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Influenza vaccination if appropriate, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Smoking cessation counseling if appropriate, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory
|
30 days after discharge
|
Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year; y/n
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography
|
30 days after discharge
|
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Smoking status post-discharge
Lasso di tempo: 30 days after discharge
|
Heart failure patients only; Exploratory
|
30 days after discharge
|
Use of inappropriate medications in the elderly, y/n
Lasso di tempo: 30 days after discharge
|
Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria
|
30 days after discharge
|
Time between discharge and visit, days
Lasso di tempo: Date of home visit
|
Exploratory
|
Date of home visit
|
Duration of physician visit, minutes
Lasso di tempo: Date of home visit
|
Exploratory
|
Date of home visit
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Jeffrey Schnipper, MD MPH, Brigham and Women's Hospital
Pubblicazioni e link utili
Pubblicazioni generali
- Epstein K, Juarez E, Loya K, Gorman MJ, Singer A. Frequency of new or worsening symptoms in the posthospitalization period. J Hosp Med. 2007 Mar;2(2):58-68. doi: 10.1002/jhm.170.
- Boling PA. Care transitions and home health care. Clin Geriatr Med. 2009 Feb;25(1):135-48, viii. doi: 10.1016/j.cger.2008.11.005.
- Meyer GS, Gibbons RV. House calls to the elderly--a vanishing practice among physicians. N Engl J Med. 1997 Dec 18;337(25):1815-20. doi: 10.1056/NEJM199712183372507.
- Wong FK, Chow SK, Chan TM, Tam SK. Comparison of effects between home visits with telephone calls and telephone calls only for transitional discharge support: a randomised controlled trial. Age Ageing. 2014 Jan;43(1):91-7. doi: 10.1093/ageing/aft123. Epub 2013 Aug 26.
- Branowicki PM, Vessey JA, Graham DA, McCabe MA, Clapp AL, Blaine K, O'Neill MR, Gouthro JA, Snydeman CK, Kline NE, Chiang VW, Cannon C, Berry JG. Meta-Analysis of Clinical Trials That Evaluate the Effectiveness of Hospital-Initiated Postdischarge Interventions on Hospital Readmission. J Healthc Qual. 2017 Nov/Dec;39(6):354-366. doi: 10.1097/JHQ.0000000000000057.
- Wolff JL, Meadow A, Boyd CM, Weiss CO, Leff B. Physician evaluation and management of Medicare home health patients. Med Care. 2009 Nov;47(11):1147-55. doi: 10.1097/MLR.0b013e3181b58e30.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- P000719
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Home visit
-
Debra FriedmanNational Cancer Institute (NCI)Attivo, non reclutante
-
University of MichiganCompletato
-
University of MichiganAttivo, non reclutanteSintomi comportamentali | Disordini mentali | Disordine depressivo | Depressione | Disturbi dell'umoreStati Uniti
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR)CompletatoFragilità | Invecchiamento | Badante | Cura di transizione | Dimissione del pazienteStati Uniti
-
University College of Northern DenmarkAalborg UniversityCompletatoDiabete mellito, tipo 2 | Esercizio | Tecnologia
-
University of MichiganAttivo, non reclutanteSintomi comportamentali | Disordine depressivo | Depressione | Disturbi dell'umore | Disordine mentaleStati Uniti
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completato
-
University Health Network, TorontoReclutamentoLinfoma | Malattie linfoproliferative | Cancro al seno Stadio I | Stadio del cancro al seno II | Cancro colorettale stadio II | Cancro colorettale Stadio III | Stadio del cancro al seno III | Cancro colorettale Stadio I | Stadio III del cancro della testa e del collo | Cancro al seno, stadio 0 | Tumore della... e altre condizioniCanada
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR)Completato